Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis

被引:28
作者
Arranz, Alicia
Abad, Catalina
Juarranz, Yasmina
Torroba, Marta
Rosignoli, Florencia
Leceta, Javier
Perez Gomariz, Rosa
Martinez, Carmen [1 ]
机构
[1] Univ Complutense, Fac Med, Dept Cell Biol, E-28040 Madrid, Spain
[2] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain
来源
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY | 2006年 / 1070卷
关键词
TLR; lymph node; inflammation; homeostasis; VIP;
D O I
10.1196/annals.1317.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs), which recognize numerous molecules collectively named pathogen-associated molecular patterns, with an essential role in inflammatory conditions and connecting innate and acquired immune responses. Moreover, a new function of TLRs in the intestinal mucosa has been described. Under homeostatic conditions, TLRs act to protect the intestinal epithelium; but when homeostasis is disrupted, TLRs appear deregulated. Disruption of intestinal homeostasis occurs in disorders, such as Crohn's disease (CD). Trinitrobenzene sulfonic acid (TNBS)induced colitis is a murine model of human CD and vasoactive intestinal polypeptide (VIP) exerts a beneficial effect, by decreasing both inflammatory and autoimmune components of the disease. Recently, we have demonstrated the constitutive expression of TLR2 and TLR4 at mRNA and protein levels in colon extracts and their upregulation in TNBStreated mice as well as the effect of VIP treatment, approaching control levels. However, the systemic effect is little known. The present results demonstrate a beneficial role of VIP, restoring homeostatic conditions through the regulation of both lymphoid cell traffic and TLR2/4 expression on macrophages (MO), dendritic cells (DCs), and CD4 and CD8 T lymphocytes.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 12 条
[1]   Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease [J].
Abad, C ;
Martinez, C ;
Juarranz, MG ;
Arranz, A ;
Leceta, J ;
Delgado, M ;
Gomariz, RP .
GASTROENTEROLOGY, 2003, 124 (04) :961-971
[2]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[3]   Adaptor usage and Toll-like receptor signaling specificity [J].
Dunne, A ;
O'Neill, LAJ .
FEBS LETTERS, 2005, 579 (15) :3330-3335
[4]   Deficient host-bacteria interactions in inflammatory bowel disease?: The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis [J].
Franchimont, D ;
Vermeire, S ;
El Housni, H ;
Pierik, M ;
Van Steen, K ;
Gustot, T ;
Quertinmont, E ;
Abramowicz, M ;
Van Gossum, A ;
Devière, J ;
Rutgeerts, P .
GUT, 2004, 53 (07) :987-992
[5]  
GLICERIO I, 2005, VET IMMUNOL IMMUNOP, V106, P229
[6]   Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP [J].
Gomariz, RP ;
Arranz, A ;
Abad, C ;
Torroba, M ;
Martinez, C ;
Rosignoli, F ;
Garcia-Gómez, M ;
Leceta, J ;
Juarranz, Y .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (02) :491-502
[7]   Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides [J].
Hornung, V ;
Rothenfusser, S ;
Britsch, S ;
Krug, A ;
Jahrsdörfer, B ;
Giese, T ;
Endres, S ;
Hartmann, G .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4531-4537
[8]   Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes [J].
Matsuguchi, T ;
Takagi, K ;
Musikacharoen, T ;
Yoshikai, Y .
BLOOD, 2000, 95 (04) :1378-1385
[9]   Strategic compartmentalization of toll-like receptor 4 in the mouse gut [J].
Ortega-Cava, CF ;
Ishihara, S ;
Rumi, MAK ;
Kawashima, K ;
Ishimura, N ;
Kazumori, H ;
Udagawa, J ;
Kadowaki, Y ;
Kinoshita, Y .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :3977-3985
[10]   Toll-like receptors and acquired immunity [J].
Pasare, C ;
Medzhitov, R .
SEMINARS IN IMMUNOLOGY, 2004, 16 (01) :23-26